MIDWEST HOLDING INC.

2023 Q4 Form 10-Q Financial Statement

#000155837023018843 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $197.8M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.721M
YoY Change -13.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $2.624B
YoY Change 55.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $2.602B
YoY Change 58.08%
SHAREHOLDERS EQUITY
Retained Earnings -$67.36M
YoY Change 26.44%
Common Stock $4.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $175.0K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $3.704M
YoY Change
Total Liabilities & Shareholders Equity $2.624B
YoY Change 55.64%

Cashflow Statement

Concept 2023 Q4 2023 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
dei Entity Central Index Key
EntityCentralIndexKey
0000355379
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
mdwt Non Voting Common Stock Shares Outstanding
NonVotingCommonStockSharesOutstanding
0
CY2022 mdwt Non Voting Common Stock Shares Outstanding
NonVotingCommonStockSharesOutstanding
0
mdwt Non Voting Common Stock Shares Outstanding
NonVotingCommonStockSharesOutstanding
0
CY2022 mdwt Non Voting Common Stock Shares Outstanding
NonVotingCommonStockSharesOutstanding
0
dei Entity Registrant Name
EntityRegistrantName
MIDWEST HOLDING INC.
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3744645
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3727976
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3744645
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3727976
CY2023Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q3 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3744645
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3727976
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39812
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0362426
dei Entity Address Address Line1
EntityAddressAddressLine1
2900 S. 70th Street, Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Lincoln
dei Entity Address State Or Province
EntityAddressStateOrProvince
NE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
 68506
dei City Area Code
CityAreaCode
402
dei Local Phone Number
LocalPhoneNumber
817-5701
dei Security12b Title
Security12bTitle
Voting Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
MDWT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3744645
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1717921000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1269735000
CY2023Q3 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
8917000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1643832000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1214635000
CY2023Q3 mdwt Mortgage Loans On Real Estate Allowance For Credit Losses
MortgageLoansOnRealEstateAllowanceForCreditLosses
1577000
CY2023Q3 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
421232000
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
227047000
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
26559000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
15934000
CY2023Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
5592000
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
5592000
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5112000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5111000
CY2023Q3 mdwt Other Investments Allowance For Credit Losses
OtherInvestmentsAllowanceForCreditLosses
1600000
CY2023Q3 us-gaap Other Investments
OtherInvestments
126777000
CY2022Q4 us-gaap Other Investments
OtherInvestments
112431000
CY2023Q3 mdwt Preferred Stock Of Non Affiliated Company
PreferredStockOfNonAffiliatedCompany
33926000
CY2022Q4 mdwt Preferred Stock Of Non Affiliated Company
PreferredStockOfNonAffiliatedCompany
31415000
CY2023Q3 mdwt Deposits And Notes Receivable
DepositsAndNotesReceivable
10774000
CY2022Q4 mdwt Deposits And Notes Receivable
DepositsAndNotesReceivable
8359000
CY2023Q3 us-gaap Policy Loans Receivable
PolicyLoansReceivable
83000
CY2022Q4 us-gaap Policy Loans Receivable
PolicyLoansReceivable
25000
CY2023Q3 us-gaap Investments
Investments
2268295000
CY2022Q4 us-gaap Investments
Investments
1614957000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
197804000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191414000
CY2023Q3 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
69470000
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
43433000
CY2023Q3 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
63000
CY2022Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
362000
CY2023Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
44694000
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
25165000
CY2023Q3 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
27870000
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
20190000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1721000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1897000
CY2022Q4 mdwt Receivables For Securities Sold
ReceivablesForSecuritiesSold
10518000
CY2023Q3 us-gaap Other Assets
OtherAssets
14335000
CY2022Q4 us-gaap Other Assets
OtherAssets
12495000
CY2023Q3 us-gaap Assets
Assets
2624252000
CY2022Q4 us-gaap Assets
Assets
1920431000
CY2023Q3 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11532000
CY2022Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
12945000
CY2023Q3 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
2453282000
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1743348000
CY2023Q3 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
4530000
CY2022Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
4105000
CY2023Q3 us-gaap Notes Payable
NotesPayable
25000000
CY2022Q4 us-gaap Notes Payable
NotesPayable
25000000
CY2023Q3 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
44140000
CY2022Q4 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
38063000
CY2023Q3 mdwt Payables For Securities Purchased
PayablesForSecuritiesPurchased
27029000
CY2022Q4 mdwt Payables For Securities Purchased
PayablesForSecuritiesPurchased
8872000
CY2023Q3 us-gaap Other Liabilities
OtherLiabilities
36786000
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
53721000
CY2023Q3 us-gaap Liabilities
Liabilities
2602299000
CY2022Q4 us-gaap Liabilities
Liabilities
1886054000
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3744645
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3727976
CY2023Q3 mdwt Non Voting Common Stock Par Or Stated Value Per Share
NonVotingCommonStockParOrStatedValuePerShare
0.001
CY2022Q4 mdwt Non Voting Common Stock Par Or Stated Value Per Share
NonVotingCommonStockParOrStatedValuePerShare
0.001
CY2023Q3 mdwt Non Voting Common Stock Shares Authorized
NonVotingCommonStockSharesAuthorized
2000000
CY2022Q4 mdwt Non Voting Common Stock Shares Authorized
NonVotingCommonStockSharesAuthorized
2000000
CY2023Q3 mdwt Non Voting Common Stock Shares Issued
NonVotingCommonStockSharesIssued
0
CY2022Q4 mdwt Non Voting Common Stock Shares Issued
NonVotingCommonStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138122000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138482000
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
175000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
175000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67361000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63019000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-66886000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51386000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3704000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23906000
CY2023Q3 us-gaap Minority Interest
MinorityInterest
18249000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
10471000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21953000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34377000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2624252000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1920431000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
20796000
CY2022Q3 us-gaap Investment Income Net
InvestmentIncomeNet
12938000
us-gaap Investment Income Net
InvestmentIncomeNet
64237000
us-gaap Investment Income Net
InvestmentIncomeNet
29721000
CY2023Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-8946000
CY2022Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
4135000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
9427000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-14676000
CY2023Q3 mdwt Amortization Of Deferred Gain On Reinsurance
AmortizationOfDeferredGainOnReinsurance
1392000
CY2022Q3 mdwt Amortization Of Deferred Gain On Reinsurance
AmortizationOfDeferredGainOnReinsurance
1239000
mdwt Amortization Of Deferred Gain On Reinsurance
AmortizationOfDeferredGainOnReinsurance
4463000
mdwt Amortization Of Deferred Gain On Reinsurance
AmortizationOfDeferredGainOnReinsurance
3251000
CY2023Q3 mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
874000
CY2022Q3 mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
536000
mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
1992000
mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
1398000
CY2023Q3 mdwt Service Fee Revenue Net Of Expenses
ServiceFeeRevenueNetOfExpenses
2298000
CY2022Q3 mdwt Service Fee Revenue Net Of Expenses
ServiceFeeRevenueNetOfExpenses
118000
mdwt Service Fee Revenue Net Of Expenses
ServiceFeeRevenueNetOfExpenses
3582000
mdwt Service Fee Revenue Net Of Expenses
ServiceFeeRevenueNetOfExpenses
1632000
CY2023Q3 us-gaap Other Income
OtherIncome
5000
CY2022Q3 us-gaap Other Income
OtherIncome
33000
us-gaap Other Income
OtherIncome
235000
us-gaap Other Income
OtherIncome
132000
CY2023Q3 us-gaap Revenues
Revenues
16419000
CY2022Q3 us-gaap Revenues
Revenues
18999000
us-gaap Revenues
Revenues
83936000
us-gaap Revenues
Revenues
21458000
CY2023Q3 mdwt Interest Credited Recurring Expense
InterestCreditedRecurringExpense
2524000
CY2022Q3 mdwt Interest Credited Recurring Expense
InterestCreditedRecurringExpense
5682000
mdwt Interest Credited Recurring Expense
InterestCreditedRecurringExpense
22803000
mdwt Interest Credited Recurring Expense
InterestCreditedRecurringExpense
-6489000
CY2023Q3 mdwt Policyholder Benefits Net
PolicyholderBenefitsNet
-526000
CY2022Q3 mdwt Policyholder Benefits Net
PolicyholderBenefitsNet
1351000
mdwt Policyholder Benefits Net
PolicyholderBenefitsNet
1638000
mdwt Policyholder Benefits Net
PolicyholderBenefitsNet
2345000
CY2023Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
2215000
CY2022Q3 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
1193000
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
5832000
us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
3095000
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3805000
CY2022Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
3751000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
15124000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
12366000
CY2023Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-956000
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-2317000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-19869000
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1744000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
8974000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
14294000
us-gaap Operating Expenses
OperatingExpenses
65266000
us-gaap Operating Expenses
OperatingExpenses
9573000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7445000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4705000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
18670000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11885000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4606000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1250000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10482000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3848000
CY2023Q3 us-gaap Profit Loss
ProfitLoss
2839000
CY2022Q3 us-gaap Profit Loss
ProfitLoss
3455000
us-gaap Profit Loss
ProfitLoss
8188000
us-gaap Profit Loss
ProfitLoss
8037000
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2454000
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3976000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7856000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-8846000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
385000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
7431000
us-gaap Net Income Loss
NetIncomeLoss
332000
us-gaap Net Income Loss
NetIncomeLoss
16883000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
2100000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
5400000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
3400000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
10400000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9937000
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-26114000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-16167000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-55483000
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-100000
CY2022Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-19900000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-200000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax
-24900000
CY2023Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-484000
CY2022Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
952000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
-667000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
94000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9453000
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27066000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-15500000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-55577000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9068000
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-19635000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15168000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-38694000
CY2022Q3 us-gaap Impairment Of Investments
ImpairmentOfInvestments
346000
us-gaap Impairment Of Investments
ImpairmentOfInvestments
880000
CY2022Q3 us-gaap Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings
346000
us-gaap Other Than Temporary Impairment Loss Debt Securities Portion Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesPortionRecognizedInEarnings
880000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.45
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
64496000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
7431000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-672000
CY2022Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-27066000
CY2022Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
4319000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39870000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
29300000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
385000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
88000
CY2023Q3 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-9453000
CY2023Q3 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1051000
CY2023Q3 us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-2684000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21953000
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
85756000
us-gaap Net Income Loss
NetIncomeLoss
16883000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-286000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-55577000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
6906000
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
39870000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34377000
us-gaap Net Income Loss
NetIncomeLoss
332000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
691000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-15500000
us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
1051000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
-7778000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21953000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
332000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
16883000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
16055000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
6982000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
281000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
229000
us-gaap Share Based Compensation
ShareBasedCompensation
691000
us-gaap Share Based Compensation
ShareBasedCompensation
-287000
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
5832000
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
3095000
us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
32425000
us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
18285000
mdwt Net Realized Gain Loss On Investments
NetRealizedGainLossOnInvestments
5950000
mdwt Net Realized Gain Loss On Investments
NetRealizedGainLossOnInvestments
-14676000
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
4751000
mdwt Deferred Coinsurance Ceding Commission
DeferredCoinsuranceCedingCommission
6077000
mdwt Deferred Coinsurance Ceding Commission
DeferredCoinsuranceCedingCommission
6875000
us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
3679000
us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-33698000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
19530000
us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
10292000
us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
-299000
us-gaap Increase Decrease In Premiums Receivable
IncreaseDecreaseInPremiumsReceivable
10000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-92184000
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
17245000
us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
-989000
us-gaap Increase Decrease In Insurance Liabilities
IncreaseDecreaseInInsuranceLiabilities
2740000
mdwt Increase Decrease In Receivable And Payable For Securities
IncreaseDecreaseInReceivableAndPayableForSecurities
-28673000
mdwt Increase Decrease In Receivable And Payable For Securities
IncreaseDecreaseInReceivableAndPayableForSecurities
-22100000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
21186000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-17697000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39306000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
64892000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
576960000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
692348000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
147965000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
296179000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
306010000
us-gaap Payments To Acquire Loans Held For Investment
PaymentsToAcquireLoansHeldForInvestment
75985000
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
110785000
us-gaap Proceeds From Sale Of Loans Held For Investment
ProceedsFromSaleOfLoansHeldForInvestment
58033000
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
22249000
us-gaap Payments For Derivative Instrument Investing Activities
PaymentsForDerivativeInstrumentInvestingActivities
22981000
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
12730000
us-gaap Proceeds From Derivative Instrument Investing Activities
ProceedsFromDerivativeInstrumentInvestingActivities
3232000
us-gaap Payments To Acquire Equity Securities Fv Ni
PaymentsToAcquireEquitySecuritiesFvNi
1000
us-gaap Proceeds From Sale Of Equity Securities Fv Ni
ProceedsFromSaleOfEquitySecuritiesFvNi
12772000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
88825000
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
48302000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
69639000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
3334000
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1700000
us-gaap Payments To Acquire Federal Home Loan Bank Stock
PaymentsToAcquireFederalHomeLoanBankStock
1000
mdwt Payments To Acquire Preferred Equity
PaymentsToAcquirePreferredEquity
2511000
mdwt Payments To Acquire Preferred Equity
PaymentsToAcquirePreferredEquity
2893000
us-gaap Payments For Proceeds From Policy Loans
PaymentsForProceedsFromPolicyLoans
58000
us-gaap Payments For Proceeds From Policy Loans
PaymentsForProceedsFromPolicyLoans
-66000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
102000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1830000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-657297000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-470724000
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
7682000
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-6906000
us-gaap Payments Of Dividends
PaymentsOfDividends
1051000
mdwt Proceeds From Deposit Contracts
ProceedsFromDepositContracts
716540000
mdwt Proceeds From Deposit Contracts
ProceedsFromDepositContracts
509660000
mdwt Withdrawals From Deposit Contracts
WithdrawalsFromDepositContracts
98790000
mdwt Withdrawals From Deposit Contracts
WithdrawalsFromDepositContracts
30271000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
624381000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
472483000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6390000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
66651000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
191414000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
142013000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
197804000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
208664000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
9682000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2870000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
mdwt Number Of Products
NumberOfProducts
6
mdwt Number Of Bonus Plans
NumberOfBonusPlans
2
CY2022Q4 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
7700000
us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
1400000
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;text-align:justify;margin:0pt 0pt 12pt 0pt;">Derivative Instruments</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Derivatives are used to hedge the risks experienced in our ongoing operations, such as equity, interest rate and cash flow risks, or for other risk management purposes, which primarily involve managing liability risks associated with our indexed annuity products and reinsurance agreements. Derivatives are financial instruments whose values are derived from interest rates, foreign exchange rates, financial indices, or other underlying notional amounts. Derivative assets and liabilities are carried at fair value on the consolidated balance sheets. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">To qualify for hedge accounting, at the inception of the hedging relationship, the Company must formally document our designation of the hedge as a cash flow or fair value hedge and our risk management objective and strategy for undertaking the hedging transaction. In this documentation, we would identify how the hedging instrument is expected to hedge the designated risks related to the hedged item, the method that would be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method which would be used to measure ineffectiveness. A derivative designated as a hedging instrument must be assessed as being highly effective in offsetting the designated risk of the hedged item. Hedge effectiveness would be formally assessed at inception and periodically throughout the life of the designated hedging relationship. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">During the last quarter of 2020, the Company began investing in futures to hedge the fluctuations in various aspects of our business. The formal documentation and hedge effectiveness was not completed at the date we entered into those futures contracts; therefore, they do not qualify for hedge accounting. The change in fair market values of these futures were recorded on our Consolidated Statements of Comprehensive Loss as realized gains or (losses). </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:0pt;margin:0pt 0pt 12pt 0pt;">Additionally, reinsurance agreements written on an FW or Modco basis contain embedded derivatives on our annuity products. Gains or (losses) associated with the performance of assets maintained in the modified coinsurance deposit and funds withheld custody accounts are reflected as realized (losses) or gains in the Consolidated Statements of Comprehensive Loss.</p>
CY2023Q3 mdwt Perpetual Preferred Stock
PerpetualPreferredStock
33900000
CY2022Q4 mdwt Perpetual Preferred Stock
PerpetualPreferredStock
31400000
CY2023Q3 mdwt Other Investments In Private Credit And Equipment Leases
OtherInvestmentsInPrivateCreditAndEquipmentLeases
13100000
CY2023Q3 mdwt Other Investments In Fund
OtherInvestmentsInFund
19000000.0
CY2023Q3 us-gaap Escrow Deposit
EscrowDeposit
1300000
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
800000
CY2023Q3 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
233500000
CY2023Q3 mdwt Federal Home Loan Bank Maximum Borrowing Capacity
FederalHomeLoanBankMaximumBorrowingCapacity
212000000.0
CY2022Q4 us-gaap Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
121100000
CY2022Q4 mdwt Federal Home Loan Bank Maximum Borrowing Capacity
FederalHomeLoanBankMaximumBorrowingCapacity
109800000
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6500000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6300000
CY2023Q3 mdwt Valuation Allowance On Policy Loans
ValuationAllowanceOnPolicyLoans
0
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
43433000
CY2021Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
24530000
us-gaap Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
32425000
CY2022 us-gaap Deferred Policy Acquisition Costs Additions
DeferredPolicyAcquisitionCostsAdditions
23857000
us-gaap Deferred Policy Acquisition Costs Amortization Expense Excluding Accrued Interest
DeferredPolicyAcquisitionCostsAmortizationExpenseExcludingAccruedInterest
-4369000
CY2022 us-gaap Deferred Policy Acquisition Costs Amortization Expense Excluding Accrued Interest
DeferredPolicyAcquisitionCostsAmortizationExpenseExcludingAccruedInterest
-3905000
mdwt Deferred Policy Acquisition Costs Amortization Expense Accrued Interest And Adjustments
DeferredPolicyAcquisitionCostsAmortizationExpenseAccruedInterestAndAdjustments
-1463000
CY2022 mdwt Deferred Policy Acquisition Costs Amortization Expense Accrued Interest And Adjustments
DeferredPolicyAcquisitionCostsAmortizationExpenseAccruedInterestAndAdjustments
-883000
us-gaap Deferred Policy Acquisition Cost Unrealized Investment Gain Loss
DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss
-556000
CY2022 us-gaap Deferred Policy Acquisition Cost Unrealized Investment Gain Loss
DeferredPolicyAcquisitionCostUnrealizedInvestmentGainLoss
-166000
CY2023Q3 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
69470000
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
43433000
CY2023Q3 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
100000
CY2022Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
400000
CY2023Q3 us-gaap Depreciation
Depreciation
100000
CY2022Q3 us-gaap Depreciation
Depreciation
100000
us-gaap Depreciation
Depreciation
300000
us-gaap Depreciation
Depreciation
100000
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1700000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1400000
CY2023Q3 us-gaap Advances From Federal Home Loan Banks
AdvancesFromFederalHomeLoanBanks
68000000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
CY2023Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-2100000
CY2022Q3 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
100000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
1800000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
14600000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000.0
CY2023Q3 mdwt Non Voting Common Stock Shares Authorized
NonVotingCommonStockSharesAuthorized
2000000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3744645
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3727976
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
385000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
7431000
us-gaap Net Income Loss
NetIncomeLoss
332000
us-gaap Net Income Loss
NetIncomeLoss
16883000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3738070
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3736933
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3734946
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3791082
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
138600
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
52000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
138600
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
52000
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3876670
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3788933
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3873546
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
3843082
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.52
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
4.45
CY2023Q3 mdwt Mortgage Loans On Real Estate Amortized Cost
MortgageLoansOnRealEstateAmortizedCost
422809000
CY2023Q3 mdwt Mortgage Loans On Real Estate Allowance For Credit Losses
MortgageLoansOnRealEstateAllowanceForCreditLosses
1577000
CY2023Q3 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
421232000
CY2023Q3 mdwt Derivative Instruments Not Designated As Hedging Instruments Asset Original Cost
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetOriginalCost
37829000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain
5296000
us-gaap Derivative Instruments Not Designated As Hedging Instruments Loss
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss
16566000
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
26559000
CY2023Q3 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
5592000
mdwt Equity Securities Gross Unrealized Losses
EquitySecuritiesGrossUnrealizedLosses
480000
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5112000
CY2023Q3 mdwt Other Investments Gross
OtherInvestmentsGross
126696000
CY2023Q3 mdwt Other Investments Allowance For Credit Losses
OtherInvestmentsAllowanceForCreditLosses
1600000
mdwt Other Investments Gross Unrealized Gains
OtherInvestmentsGrossUnrealizedGains
2154000
mdwt Other Investments Gross Unrealized Loss
OtherInvestmentsGrossUnrealizedLoss
473000
CY2023Q3 us-gaap Other Investments
OtherInvestments
126777000
CY2023Q3 mdwt Investment In Preferred Stock Amortized Cost
InvestmentInPreferredStockAmortizedCost
38801000
CY2023Q3 mdwt Investment In Preferred Stock Gross Unrealized Gains
InvestmentInPreferredStockGrossUnrealizedGains
177000
CY2023Q3 mdwt Investment In Preferred Stock Gross Unrealized Losses
InvestmentInPreferredStockGrossUnrealizedLosses
5052000
CY2023Q3 mdwt Investment In Preferred Stock Fair Value
InvestmentInPreferredStockFairValue
33926000
CY2023Q3 mdwt Deposits And Notes Receivable Amortized Cost
DepositsAndNotesReceivableAmortizedCost
10774000
CY2023Q3 mdwt Deposits And Notes Receivable Fair Value Disclosure
DepositsAndNotesReceivableFairValueDisclosure
10774000
mdwt Policy Loans
PolicyLoans
83000
mdwt Policy Loans
PolicyLoans
83000
CY2023Q3 mdwt Investments Available For Sale Amortized Cost
InvestmentsAvailableForSaleAmortizedCost
2360505000
CY2023Q3 mdwt Investments Allowance For Credit Losses
InvestmentsAllowanceForCreditLosses
10714000
mdwt Available For Sale Investments Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleInvestmentsAccumulatedGrossUnrealizedGainBeforeTax
15719000
CY2023Q3 mdwt Available For Sale Investments Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleInvestmentsAccumulatedGrossUnrealizedLossBeforeTax
97215000
CY2023Q3 mdwt Investments Available For Sale Fair Value Disclosure
InvestmentsAvailableForSaleFairValueDisclosure
2268295000
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
227047000
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
227047000
CY2022Q4 mdwt Derivative Instruments Not Designated As Hedging Instruments Asset Original Cost
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetOriginalCost
30239000
CY2022 us-gaap Derivative Instruments Not Designated As Hedging Instruments Gain
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGain
2694000
CY2022 us-gaap Derivative Instruments Not Designated As Hedging Instruments Loss
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLoss
16999000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
15934000
CY2022Q4 us-gaap Equity Securities Fv Ni Cost
EquitySecuritiesFvNiCost
5592000
CY2022 mdwt Equity Securities Gross Unrealized Losses
EquitySecuritiesGrossUnrealizedLosses
481000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5111000
CY2022Q4 mdwt Other Investments Gross
OtherInvestmentsGross
108979000
CY2022 mdwt Other Investments Gross Unrealized Gains
OtherInvestmentsGrossUnrealizedGains
3667000
CY2022 mdwt Other Investments Gross Unrealized Loss
OtherInvestmentsGrossUnrealizedLoss
215000
CY2022Q4 us-gaap Other Investments
OtherInvestments
112431000
CY2022Q4 mdwt Investment In Preferred Stock Amortized Cost
InvestmentInPreferredStockAmortizedCost
35644000
CY2022Q4 mdwt Investment In Preferred Stock Gross Unrealized Gains
InvestmentInPreferredStockGrossUnrealizedGains
1757000
CY2022Q4 mdwt Investment In Preferred Stock Gross Unrealized Losses
InvestmentInPreferredStockGrossUnrealizedLosses
5986000
CY2022Q4 mdwt Investment In Preferred Stock Fair Value
InvestmentInPreferredStockFairValue
31415000
CY2022Q4 mdwt Deposits And Notes Receivable Amortized Cost
DepositsAndNotesReceivableAmortizedCost
8359000
CY2022Q4 mdwt Deposits And Notes Receivable Fair Value Disclosure
DepositsAndNotesReceivableFairValueDisclosure
8359000
CY2022 mdwt Policy Loans
PolicyLoans
25000
CY2022 mdwt Policy Loans
PolicyLoans
25000
CY2022Q4 mdwt Investments Available For Sale Amortized Cost
InvestmentsAvailableForSaleAmortizedCost
1685620000
CY2022 mdwt Available For Sale Investments Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleInvestmentsAccumulatedGrossUnrealizedGainBeforeTax
11668000
CY2022Q4 mdwt Available For Sale Investments Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleInvestmentsAccumulatedGrossUnrealizedLossBeforeTax
82331000
CY2022Q4 mdwt Investments Available For Sale Fair Value Disclosure
InvestmentsAvailableForSaleFairValueDisclosure
1614957000
mdwt Mortgage Loans On Real Estate Allowance For Credit Losses Expense Reversals
MortgageLoansOnRealEstateAllowanceForCreditLossesExpenseReversals
447000
CY2023Q3 mdwt Mortgage Loans On Real Estate Allowance For Credit Losses
MortgageLoansOnRealEstateAllowanceForCreditLosses
1577000
mdwt Other Investments Allowance For Credit Losses Expense Reversal
OtherInvestmentsAllowanceForCreditLossesExpenseReversal
103000
CY2023Q3 mdwt Other Investments Allowance For Credit Losses
OtherInvestmentsAllowanceForCreditLosses
1600000
mdwt Investments Allowance For Credit Losses Expense Reversal
InvestmentsAllowanceForCreditLossesExpenseReversal
5956000
CY2023Q3 mdwt Investments Allowance For Credit Losses
InvestmentsAllowanceForCreditLosses
10714000
CY2023Q2 mdwt Mortgage Loans On Real Estate Allowance For Credit Losses
MortgageLoansOnRealEstateAllowanceForCreditLosses
1493000
CY2023Q3 mdwt Mortgage Loans On Real Estate Allowance For Credit Losses Expense Reversals
MortgageLoansOnRealEstateAllowanceForCreditLossesExpenseReversals
-84000
CY2023Q3 mdwt Mortgage Loans On Real Estate Allowance For Credit Losses
MortgageLoansOnRealEstateAllowanceForCreditLosses
1577000
CY2023Q2 mdwt Other Investments Allowance For Credit Losses
OtherInvestmentsAllowanceForCreditLosses
1343000
CY2023Q3 mdwt Other Investments Allowance For Credit Losses Expense Reversal
OtherInvestmentsAllowanceForCreditLossesExpenseReversal
-257000
CY2023Q3 mdwt Other Investments Allowance For Credit Losses
OtherInvestmentsAllowanceForCreditLosses
1600000
CY2023Q2 mdwt Investments Allowance For Credit Losses
InvestmentsAllowanceForCreditLosses
11752000
CY2023Q3 mdwt Investments Allowance For Credit Losses Expense Reversal
InvestmentsAllowanceForCreditLossesExpenseReversal
1038000
CY2023Q3 mdwt Investments Allowance For Credit Losses
InvestmentsAllowanceForCreditLosses
10714000
mdwt Available For Sale Investments Unrealized Gain Impairment Allowances
AvailableForSaleInvestmentsUnrealizedGainImpairmentAllowances
0
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
199892000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
195433000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
879623000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
860178000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
433369000
CY2023Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
401992000
CY2023Q3 mdwt Available For Sale Securities Debt Maturities After Ten Through Twenty Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenThroughTwentyYearsAmortizedCost
162978000
CY2023Q3 mdwt Available For Sale Securities Debt Maturities After Ten Years Through Twenty Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsThroughTwentyYearsFairValue
152915000
CY2023Q3 mdwt Available For Sale Securities Debt Maturities After Twenty Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTwentyYearsAmortizedCost
42059000
CY2023Q3 mdwt Available For Sale Securities Debt Maturities After Twenty Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTwentyYearsFairValue
33314000
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
1717921000
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
1643832000
CY2023Q3 mdwt Assets On Deposit Amortized Cost
AssetsOnDepositAmortizedCost
1700000
CY2022Q4 mdwt Assets On Deposit Amortized Cost
AssetsOnDepositAmortizedCost
1200000
CY2023Q3 mdwt Assets On Deposits Fair Value
AssetsOnDepositsFairValue
1700000
CY2022Q4 mdwt Assets On Deposits Fair Value
AssetsOnDepositsFairValue
1000000.0
CY2023Q3 mdwt Mortgage Loans On Real Estate Allowance For Credit Losses
MortgageLoansOnRealEstateAllowanceForCreditLosses
1577000
CY2023Q3 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
421232000
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
227047000
CY2023Q3 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
7700000
us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
1400000
CY2022Q4 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
7700000
CY2022 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
1400000
CY2023Q3 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
421232000
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
227047000
CY2023Q3 us-gaap Net Investment Income
NetInvestmentIncome
68021000
CY2022Q3 us-gaap Net Investment Income
NetInvestmentIncome
34585000
us-gaap Net Investment Income
NetInvestmentIncome
172636000
us-gaap Net Investment Income
NetInvestmentIncome
114343000
CY2023Q3 mdwt Investment Income Investment Expense Net Of Refund
InvestmentIncomeInvestmentExpenseNetOfRefund
9447000
CY2022Q3 mdwt Investment Income Investment Expense Net Of Refund
InvestmentIncomeInvestmentExpenseNetOfRefund
3911000
mdwt Investment Income Investment Expense Net Of Refund
InvestmentIncomeInvestmentExpenseNetOfRefund
20711000
mdwt Investment Income Investment Expense Net Of Refund
InvestmentIncomeInvestmentExpenseNetOfRefund
25273000
CY2023Q3 mdwt Investment Expenses Amount Charged To Reinsurers
InvestmentExpensesAmountChargedToReinsurers
37778000
CY2022Q3 mdwt Investment Expenses Amount Charged To Reinsurers
InvestmentExpensesAmountChargedToReinsurers
17736000
mdwt Investment Expenses Amount Charged To Reinsurers
InvestmentExpensesAmountChargedToReinsurers
87688000
mdwt Investment Expenses Amount Charged To Reinsurers
InvestmentExpensesAmountChargedToReinsurers
59349000
CY2023Q3 mdwt Investment Income Less Investment Expenses
InvestmentIncomeLessInvestmentExpenses
20796000
CY2022Q3 mdwt Investment Income Less Investment Expenses
InvestmentIncomeLessInvestmentExpenses
12938000
mdwt Investment Income Less Investment Expenses
InvestmentIncomeLessInvestmentExpenses
64237000
mdwt Investment Income Less Investment Expenses
InvestmentIncomeLessInvestmentExpenses
29721000
CY2023Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
15000000.0
CY2022Q3 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
94000000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
28000000.0
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
187600000
CY2023Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
600000
CY2022Q3 us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
100000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
900000
us-gaap Debt Securities Available For Sale Realized Gain
DebtSecuritiesAvailableForSaleRealizedGain
1500000
CY2023Q3 mdwt Unrealized Gains Losses On Investments Assets Of Third Party Reinsurers Retained By Entity
UnrealizedGainsLossesOnInvestmentsAssetsOfThirdPartyReinsurersRetainedByEntity
-14200000
CY2022Q3 mdwt Unrealized Gains Losses On Investments Assets Of Third Party Reinsurers Retained By Entity
UnrealizedGainsLossesOnInvestmentsAssetsOfThirdPartyReinsurersRetainedByEntity
10500000
mdwt Unrealized Gains Losses On Investments Assets Of Third Party Reinsurers Retained By Entity
UnrealizedGainsLossesOnInvestmentsAssetsOfThirdPartyReinsurersRetainedByEntity
16600000
mdwt Unrealized Gains Losses On Investments Assets Of Third Party Reinsurers Retained By Entity
UnrealizedGainsLossesOnInvestmentsAssetsOfThirdPartyReinsurersRetainedByEntity
16800000
us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-12300000
CY2022 us-gaap Debt And Equity Securities Unrealized Gain Loss
DebtAndEquitySecuritiesUnrealizedGainLoss
-10500000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
1800000
us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
14600000
CY2023Q3 us-gaap Escrow Deposit
EscrowDeposit
1300000
CY2022Q4 us-gaap Escrow Deposit
EscrowDeposit
800000
CY2023Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6500000
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
6300000
CY2022Q4 us-gaap Financial Instruments Owned Mortgages Mortgage Backed And Asset Backed Securities At Fair Value
FinancialInstrumentsOwnedMortgagesMortgageBackedAndAssetBackedSecuritiesAtFairValue
7700000
CY2022 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
1400000
CY2023Q3 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
421232000
CY2023Q3 us-gaap Derivative Assets
DerivativeAssets
26559000
CY2023Q3 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5112000
CY2023Q3 us-gaap Other Investments
OtherInvestments
126777000
CY2023Q3 mdwt Preferred Stock Of Non Affiliated Company
PreferredStockOfNonAffiliatedCompany
33926000
CY2023Q3 mdwt Deposits And Notes Receivable Fair Value Disclosure
DepositsAndNotesReceivableFairValueDisclosure
10774000
mdwt Policy Loans
PolicyLoans
83000
CY2023Q3 mdwt Investments Available For Sale Fair Value Disclosure
InvestmentsAvailableForSaleFairValueDisclosure
2268295000
CY2023Q3 mdwt Embedded Derivative Liability Fair Value Disclosure
EmbeddedDerivativeLiabilityFairValueDisclosure
146143000
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
227047000
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
15934000
CY2022Q4 us-gaap Equity Securities Fv Ni
EquitySecuritiesFvNi
5111000
CY2022Q4 us-gaap Other Investments
OtherInvestments
112431000
CY2022Q4 mdwt Preferred Stock Of Non Affiliated Company
PreferredStockOfNonAffiliatedCompany
31415000
CY2022Q4 mdwt Deposits And Notes Receivable Fair Value Disclosure
DepositsAndNotesReceivableFairValueDisclosure
8359000
CY2022 mdwt Policy Loans
PolicyLoans
25000
CY2022Q4 mdwt Investments Available For Sale Fair Value Disclosure
InvestmentsAvailableForSaleFairValueDisclosure
1614957000
CY2022Q4 mdwt Embedded Derivative Liability Fair Value Disclosure
EmbeddedDerivativeLiabilityFairValueDisclosure
111618000
CY2023Q3 mdwt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2022Q4 mdwt Fair Value Assets Transfers Between Levels Amount
FairValueAssetsTransfersBetweenLevelsAmount
0
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1743348000
CY2021Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1075439000
mdwt Deposits Contract Us Alliance
DepositsContractUsAlliance
-452000
CY2022 mdwt Deposits Contract Us Alliance
DepositsContractUsAlliance
-2176000
mdwt Deposit Contract Unified Life Insurance Company
DepositContractUnifiedLifeInsuranceCompany
-129000
CY2022 mdwt Deposit Contract Unified Life Insurance Company
DepositContractUnifiedLifeInsuranceCompany
-10000
mdwt Deposit Contracts Received
DepositContractsReceived
755213000
CY2022 mdwt Deposit Contracts Received
DepositContractsReceived
745083000
mdwt Deposit Contracts Investment Earnings
DepositContractsInvestmentEarnings
33170000
CY2022 mdwt Deposit Contracts Investment Earnings
DepositContractsInvestmentEarnings
-10193000
mdwt Deposit Contracts Withdrawals Net
DepositContractsWithdrawalsNet
-95165000
CY2022Q3 mdwt Interest On Ceding Commissions
InterestOnCedingCommissions
230000
CY2022Q3 mdwt Earned Ceding Commission Net
EarnedCedingCommissionNet
1239000
mdwt Ceded Commission Earned
CededCommissionEarned
7812000
mdwt Expense Allowances
ExpenseAllowances
7380000
CY2022 mdwt Deposit Contracts Withdrawals Net
DepositContractsWithdrawalsNet
-51659000
CY2022 mdwt Deposits Contracts Policy Charges
DepositsContractsPolicyCharges
-820000
CY2023Q3 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
2453282000
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1743348000
CY2023Q3 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
27870000
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
20190000
CY2023Q3 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
2453282000
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1743348000
CY2023Q3 us-gaap Liabilities For Guarantees On Long Duration Contracts Reinsurance Recoverable
LiabilitiesForGuaranteesOnLongDurationContractsReinsuranceRecoverable
1157854000
CY2022Q4 us-gaap Liabilities For Guarantees On Long Duration Contracts Reinsurance Recoverable
LiabilitiesForGuaranteesOnLongDurationContractsReinsuranceRecoverable
912982000
CY2023Q3 us-gaap Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Net
LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityNet
1295428000
CY2022Q4 us-gaap Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Net
LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityNet
830366000
CY2023Q3 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
324000
CY2023Q3 mdwt Reinsurance Recoverable On Benefit Reserve
ReinsuranceRecoverableOnBenefitReserve
27598000
CY2023Q3 mdwt Reinsurance Recoverable On Ceded Due Premiums
ReinsuranceRecoverableOnCededDuePremiums
-52000
CY2023Q3 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
27870000
CY2022Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
195000
CY2022Q4 mdwt Reinsurance Recoverable On Benefit Reserve
ReinsuranceRecoverableOnBenefitReserve
20337000
CY2022Q4 mdwt Reinsurance Recoverable On Ceded Due Premiums
ReinsuranceRecoverableOnCededDuePremiums
-342000
CY2022Q4 us-gaap Reinsurance Recoverables
ReinsuranceRecoverables
20190000
CY2023Q3 mdwt Ceded Commission Earned
CededCommissionEarned
1384000
CY2023Q3 mdwt Expense Allowances
ExpenseAllowances
1207000
CY2023Q3 mdwt Interest On Ceding Commissions
InterestOnCedingCommissions
358000
CY2023Q3 mdwt Earned Ceding Commission Net
EarnedCedingCommissionNet
1392000
CY2022Q3 mdwt Ceded Commission Earned
CededCommissionEarned
3994000
CY2022Q3 mdwt Expense Allowances
ExpenseAllowances
5209000
mdwt Interest On Ceding Commissions
InterestOnCedingCommissions
986000
mdwt Earned Ceding Commission Net
EarnedCedingCommissionNet
4463000
mdwt Ceded Commission Earned
CededCommissionEarned
8346000
mdwt Expense Allowances
ExpenseAllowances
12668000
mdwt Interest On Ceding Commissions
InterestOnCedingCommissions
623000
mdwt Earned Ceding Commission Net
EarnedCedingCommissionNet
3251000
CY2023Q3 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
44140000
CY2022Q4 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
38063000
CY2023Q3 mdwt Contingency Reserves
ContingencyReserves
0
CY2022Q4 mdwt Contingency Reserves
ContingencyReserves
0
CY2023Q3 us-gaap Investments
Investments
1212973000
CY2023Q3 us-gaap Investments
Investments
1055322000
CY2023Q3 us-gaap Investments
Investments
2268295000
CY2022Q4 us-gaap Investments
Investments
812177000
CY2022Q4 us-gaap Investments
Investments
802780000
CY2022Q4 us-gaap Investments
Investments
1614957000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
111119000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86685000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
197804000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
127291000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
64123000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191414000
CY2023Q3 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
69470000
CY2023Q3 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
69470000
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
43433000
CY2022Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
43433000
CY2023Q3 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
63000
CY2023Q3 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
63000
CY2023Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
18835000
CY2023Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
25859000
CY2023Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
44694000
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
11307000
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
13858000
CY2022Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
25165000
CY2023Q3 mdwt Reinsurance Recoverables And Premiums Receivable
ReinsuranceRecoverablesAndPremiumsReceivable
-8944000
CY2023Q3 mdwt Reinsurance Recoverables And Premiums Receivable
ReinsuranceRecoverablesAndPremiumsReceivable
36814000
CY2023Q3 mdwt Reinsurance Recoverables And Premiums Receivable
ReinsuranceRecoverablesAndPremiumsReceivable
27870000
CY2022Q4 mdwt Reinsurance Recoverables And Premiums Receivable
ReinsuranceRecoverablesAndPremiumsReceivable
-6853000
CY2022Q4 mdwt Reinsurance Recoverables And Premiums Receivable
ReinsuranceRecoverablesAndPremiumsReceivable
27405000
CY2022Q4 mdwt Reinsurance Recoverables And Premiums Receivable
ReinsuranceRecoverablesAndPremiumsReceivable
20552000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1721000
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1721000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1897000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1897000
CY2023Q3 mdwt Receivables For Securities Sold
ReceivablesForSecuritiesSold
-9650000
CY2023Q3 mdwt Receivables For Securities Sold
ReceivablesForSecuritiesSold
9650000
CY2022Q4 mdwt Receivables For Securities Sold
ReceivablesForSecuritiesSold
2033000
CY2022Q4 mdwt Other General Liabilities
OtherGeneralLiabilities
49815000
CY2022Q4 mdwt Other General Liabilities
OtherGeneralLiabilities
3906000
CY2022Q4 mdwt Other General Liabilities
OtherGeneralLiabilities
53721000
CY2023Q3 us-gaap Liabilities
Liabilities
1386331000
CY2023Q3 us-gaap Liabilities
Liabilities
1215968000
CY2022Q4 mdwt Receivables For Securities Sold
ReceivablesForSecuritiesSold
8485000
CY2022Q4 mdwt Receivables For Securities Sold
ReceivablesForSecuritiesSold
10518000
CY2023Q3 mdwt Other General Assets
OtherGeneralAssets
12760000
CY2023Q3 mdwt Other General Assets
OtherGeneralAssets
1575000
CY2023Q3 mdwt Other General Assets
OtherGeneralAssets
14335000
CY2022Q4 mdwt Other General Assets
OtherGeneralAssets
12259000
CY2022Q4 mdwt Other General Assets
OtherGeneralAssets
236000
CY2022Q4 mdwt Other General Assets
OtherGeneralAssets
12495000
CY2023Q3 us-gaap Assets
Assets
1408284000
CY2023Q3 us-gaap Assets
Assets
1215968000
CY2023Q3 us-gaap Assets
Assets
2624252000
CY2022Q4 us-gaap Assets
Assets
1003544000
CY2022Q4 us-gaap Assets
Assets
916887000
CY2022Q4 us-gaap Assets
Assets
1920431000
CY2023Q3 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
526000
CY2023Q3 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11006000
CY2023Q3 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11532000
CY2022Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
1332000
CY2022Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
11613000
CY2022Q4 us-gaap Liability For Future Policy Benefits
LiabilityForFuturePolicyBenefits
12945000
CY2023Q3 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1301754000
CY2023Q3 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1151528000
CY2023Q3 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
2453282000
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
841980000
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
901368000
CY2022Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
1743348000
CY2023Q3 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
4219000
CY2023Q3 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
311000
CY2023Q3 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
4530000
CY2022Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
4105000
CY2022Q4 us-gaap Other Policyholder Funds
OtherPolicyholderFunds
4105000
CY2023Q3 us-gaap Notes Payable
NotesPayable
25000000
CY2023Q3 us-gaap Notes Payable
NotesPayable
25000000
CY2022Q4 us-gaap Notes Payable
NotesPayable
25000000
CY2022Q4 us-gaap Notes Payable
NotesPayable
25000000
CY2023Q3 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
416000
CY2023Q3 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
43724000
CY2023Q3 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
44140000
CY2022Q4 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
38063000
CY2022Q4 mdwt Deferred Gain On Coinsurance Transaction
DeferredGainOnCoinsuranceTransaction
38063000
CY2023Q3 mdwt Payables For Securities Purchased
PayablesForSecuritiesPurchased
27029000
CY2023Q3 mdwt Payables For Securities Purchased
PayablesForSecuritiesPurchased
27029000
CY2022Q4 mdwt Payables For Securities Purchased
PayablesForSecuritiesPurchased
8872000
CY2022Q4 mdwt Payables For Securities Purchased
PayablesForSecuritiesPurchased
8872000
CY2023Q3 mdwt Other General Liabilities
OtherGeneralLiabilities
27387000
CY2023Q3 mdwt Other General Liabilities
OtherGeneralLiabilities
9399000
CY2023Q3 mdwt Other General Liabilities
OtherGeneralLiabilities
36786000
CY2023Q3 us-gaap Liabilities
Liabilities
2602299000
CY2022Q4 us-gaap Liabilities
Liabilities
969167000
CY2022Q4 us-gaap Liabilities
Liabilities
916887000
CY2022Q4 us-gaap Liabilities
Liabilities
1886054000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2023Q3 mdwt Additional Paid In Capital Including Adjustments
AdditionalPaidInCapitalIncludingAdjustments
138122000
CY2023Q3 mdwt Additional Paid In Capital Including Adjustments
AdditionalPaidInCapitalIncludingAdjustments
138122000
CY2022Q4 mdwt Additional Paid In Capital Including Adjustments
AdditionalPaidInCapitalIncludingAdjustments
138482000
CY2022Q4 mdwt Additional Paid In Capital Including Adjustments
AdditionalPaidInCapitalIncludingAdjustments
138482000
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
175000
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
175000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
175000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
175000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67361000
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67361000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63019000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63019000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-66886000
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-66886000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51386000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51386000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3704000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3704000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23906000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23906000
CY2023Q3 us-gaap Minority Interest
MinorityInterest
18249000
CY2023Q3 us-gaap Minority Interest
MinorityInterest
18249000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
10471000
CY2022Q4 us-gaap Minority Interest
MinorityInterest
10471000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21953000
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
21953000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34377000
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
34377000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1408284000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1215968000
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2624252000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1003544000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
916887000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1920431000
CY2023Q3 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
4146000
CY2022Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
2672000
CY2023Q3 mdwt Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
44000
CY2022Q4 mdwt Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
79000
CY2023Q3 mdwt Deferred Tax Assets Stock Option Granted
DeferredTaxAssetsStockOptionGranted
1190000
CY2022Q4 mdwt Deferred Tax Assets Stock Option Granted
DeferredTaxAssetsStockOptionGranted
1066000
CY2023Q3 mdwt Deferred Tax Assets Policy Acquisition Costs
DeferredTaxAssetsPolicyAcquisitionCosts
9803000
CY2022Q4 mdwt Deferred Tax Assets Policy Acquisition Costs
DeferredTaxAssetsPolicyAcquisitionCosts
6489000
CY2023Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
6000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
6000
CY2023Q3 mdwt Deferred Tax Assets Business Interest Expenses
DeferredTaxAssetsBusinessInterestExpenses
171000
CY2022Q4 mdwt Deferred Tax Assets Business Interest Expenses
DeferredTaxAssetsBusinessInterestExpenses
171000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
17189000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
12010000
CY2023Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
535000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Impairment Losses
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsImpairmentLosses
403000
CY2023Q3 mdwt Deferred Tax Assets Unrealized Losses On Investments
DeferredTaxAssetsUnrealizedLossesOnInvestments
17780000
CY2022Q4 mdwt Deferred Tax Assets Unrealized Losses On Investments
DeferredTaxAssetsUnrealizedLossesOnInvestments
13624000
CY2023Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1928000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1928000
CY2023Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
52792000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38448000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46138000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
35305000
CY2023Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
6654000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3143000
CY2023Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
147000
CY2022Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
147000
CY2023Q3 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
4246000
CY2022Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
2150000
CY2023Q3 mdwt Deferred Tax Liabilities Bond Discount
DeferredTaxLiabilitiesBondDiscount
2400000
CY2022Q4 mdwt Deferred Tax Liabilities Bond Discount
DeferredTaxLiabilitiesBondDiscount
936000
CY2023Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
139000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
90000
CY2023Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
6654000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
3143000
CY2023Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
46100000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
35300000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4600000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3800000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-1564000
CY2022Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-796000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-3921000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-2305000
CY2023Q3 mdwt Effective Income Tax Rate Reconciliation Imr And Reinsurance
EffectiveIncomeTaxRateReconciliationImrAndReinsurance
-47000
CY2022Q3 mdwt Effective Income Tax Rate Reconciliation Imr And Reinsurance
EffectiveIncomeTaxRateReconciliationImrAndReinsurance
176000
mdwt Effective Income Tax Rate Reconciliation Imr And Reinsurance
EffectiveIncomeTaxRateReconciliationImrAndReinsurance
4000
mdwt Effective Income Tax Rate Reconciliation Imr And Reinsurance
EffectiveIncomeTaxRateReconciliationImrAndReinsurance
158000
CY2023Q3 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-3000
CY2022Q3 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-3000
us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-9000
us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-8000
CY2023Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-2896000
CY2022Q3 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-641000
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-6677000
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1693000
CY2022Q3 mdwt Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssets
-14000
CY2023Q3 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-19000
us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-19000
CY2023Q3 us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
-77000
us-gaap Income Tax Reconciliation Prior Year Income Taxes
IncomeTaxReconciliationPriorYearIncomeTaxes
140000
CY2023Q3 mdwt Income Tax Reconciliation Deduction
IncomeTaxReconciliationDeduction
-3042000
CY2022Q3 mdwt Income Tax Reconciliation Deduction
IncomeTaxReconciliationDeduction
-454000
mdwt Income Tax Reconciliation Deduction
IncomeTaxReconciliationDeduction
-6561000
mdwt Income Tax Reconciliation Deduction
IncomeTaxReconciliationDeduction
-1543000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4606000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1250000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10482000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3848000
CY2023Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
10600000
CY2016Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
900000
mdwt Percentage Of Carry Forward Year Limited Taxable Income
PercentageOfCarryForwardYearLimitedTaxableIncome
0.80
CY2023Q3 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
2200000
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1997000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2119000
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2005000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2135000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3000
us-gaap Operating Lease Cost
OperatingLeaseCost
10000
us-gaap Operating Lease Cost
OperatingLeaseCost
10000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.0426
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
2.873
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.037
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
112000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
378000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
342000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
345000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
353000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
362000
CY2023Q3 mdwt Lessee Operating Lease Liability Payments Due Year Five And After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndAfterYearFive
1041000
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2933000
mdwt Operating Lease Operating Cash Flows
OperatingLeaseOperatingCashFlows
100000
CY2022Q3 mdwt Operating Lease Operating Cash Flows
OperatingLeaseOperatingCashFlows
100000
mdwt Operating Lease Operating Cash Flows
OperatingLeaseOperatingCashFlows
100000
CY2023Q3 mdwt Operating Lease Operating Cash Flows
OperatingLeaseOperatingCashFlows
100000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.08
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2000000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3744645
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3727976
CY2023Q3 mdwt Non Voting Common Stock Shares Issued
NonVotingCommonStockSharesIssued
0
CY2022Q4 mdwt Non Voting Common Stock Shares Issued
NonVotingCommonStockSharesIssued
0
us-gaap Stock Issued During Period Shares Reverse Stock Splits
StockIssuedDuringPeriodSharesReverseStockSplits
4500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.873
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
32.19
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
319121
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
271517
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
47604
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
17.12
mdwt Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodExercisePrice
17.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5750
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5750
mdwt Share Based Compensation Arrangements By Share Based Payment Award Options Prior Period Adjustment Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsPriorPeriodAdjustmentWeightedAverageExercisePrice
39.16
mdwt Share Based Compensation Arrangement By Share Based Payment Award Options Prior Period Adjustment Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsPriorPeriodAdjustmentGross
-7390
mdwt Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Prior Period Adjustment Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisablePriorPeriodAdjustmentNumber
7390
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.92
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
19267
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
19267
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
30.90
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
305604
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
250610
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
54994
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.0416
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M14D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0357
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0357
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0002
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0215
CY2023Q3 mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
900000
CY2022Q3 mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
500000
mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
2000000.0
mdwt Policy Charges On Deposit Contracts
PolicyChargesOnDepositContracts
1400000

Files In Submission

Name View Source Status
0001558370-23-018843-index-headers.html Edgar Link pending
0001558370-23-018843-index.html Edgar Link pending
0001558370-23-018843.txt Edgar Link pending
0001558370-23-018843-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mdwt-20230930.xsd Edgar Link pending
mdwt-20230930x10q.htm Edgar Link pending
mdwt-20230930xex31d1.htm Edgar Link pending
mdwt-20230930xex31d2.htm Edgar Link pending
mdwt-20230930xex32d1.htm Edgar Link pending
mdwt-20230930xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
mdwt-20230930_lab.xml Edgar Link unprocessable
mdwt-20230930_pre.xml Edgar Link unprocessable
mdwt-20230930_def.xml Edgar Link unprocessable
mdwt-20230930_cal.xml Edgar Link unprocessable
mdwt-20230930x10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending